Timothy Daley
Stock Analyst at Wells Fargo
(2.01)
# 3,084
Out of 5,122 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $52.18 | -14.79% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $5.47 | +265.63% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $107.09 | -11.29% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $43.75 | +64.57% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $135.39 | +7.10% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,385.61 | -6.18% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $379.31 | -24.86% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $223.42 | +10.55% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $213.22 | +28.97% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $270.29 | -0.11% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $10.25 | +173.17% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $15.73 | +122.50% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $581.77 | -10.62% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.51 | +1,679.71% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $151.12 | +22.42% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.74 | +13.73% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $231.23 | -4.86% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $178.59 | +23.19% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $11.07 | +152.94% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $185.00 | -24.32% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $65.25 | +37.93% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $52.18
Upside: -14.79%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $5.47
Upside: +265.63%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $107.09
Upside: -11.29%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $43.75
Upside: +64.57%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $135.39
Upside: +7.10%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,385.61
Upside: -6.18%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $379.31
Upside: -24.86%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $223.42
Upside: +10.55%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $213.22
Upside: +28.97%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $270.29
Upside: -0.11%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $10.25
Upside: +173.17%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $15.73
Upside: +122.50%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $581.77
Upside: -10.62%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.51
Upside: +1,679.71%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $151.12
Upside: +22.42%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.74
Upside: +13.73%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $231.23
Upside: -4.86%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $178.59
Upside: +23.19%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $11.07
Upside: +152.94%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $185.00
Upside: -24.32%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $65.25
Upside: +37.93%